Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE

av Eastell, R., Mitlak, B. H., Wang, Y., Hu, M., Fitzpatrick, L. A., Black, D. M.
I publikationen Osteoporos Int (2019)

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial

av Watts, N.B., Dore, R.K., Baim, S., Mitlak, B., Hattersley, G., Wang, Y., Rozental, T.D., LeBoff, M.S.
I publikationen Osteoporos Int (2020)

Tools in the assessment of sarcopenia

av Cooper, C, Fielding, R, Visser, M, van Loon, LJ, Rolland, Y, Orwoll, E, Reid, K, Boonen, S, Dere, W, Epstein, S, Mitlak, B, Tsouderos, Y, Sayer, AA, Rizzoli, R, Reginster, JY, Kanis, JA
Publicerad 2013

Treatment of osteoporosis in men

av Kaufman, J.-M., Reginster, J.-Y., Boonen, S., Brandi, M. L., Cooper, C., Dere, W., Devogelaer, J.-P., Diez-Perez, A., Kanis, J. A., McCloskey, E., Mitlak, B., Orwoll, E., Ringe, J.D., Weryha, G., Rizzoli, R.
Publicerad 2012